Medacta Group SA (MOVE.SW) stock: key figures, P/E, revenue and dividend
Health Care · Switzerland · ISIN CH0468525222
Medacta Group SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 590.32 m EUR | 688.00 m EUR |
| Gross profit | 399.21 m EUR | 440.62 m EUR |
| EBIT | 90.25 m EUR | 114.67 m EUR |
| Net income | 72.20 m EUR | 95.56 m EUR |
| Diluted EPS – continuing operations | 3.65 EUR | 4.78 EUR |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
More stocks
- Shanghai Jin Jiang International Hotels Development Co Ltd A (600754.SS)
- Canal+ SA (CAN.L)
- Tongding Interconnection Information (002491.SZ)
- DIC Corp (4631.T)
- Privia Health Group, Inc. (PRVA)
- China South Publishing & Media Group Co Ltd (601098.SS)
- Easy Click Worldwide Network Technology Co. Ltd. A (301171.SZ)
- DANA Inc (DAN)
- MCGRATH RENTCORP (MGRC)
- Tianneng Battery Group Co Ltd (688819.SS)
- WD 40 CO (WDFC)
- Primarius Technologies Co. Ltd. A (688206.SS)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.